Senseonics, Inc.
Clinical trials sponsored by Senseonics, Inc., explained in plain language.
-
New sensor aims to improve diabetes monitoring
Disease control Recruiting nowThis study tests a new glucose sensor (ROME GS) to see if it is as accurate and safe as an existing sensor. It involves 60 adults with type 1 or type 2 diabetes. The sensor measures glucose levels continuously, and researchers will check for any side effects or errors.
Phase: NA • Sponsor: Senseonics, Inc. • Aim: Disease control
Last updated May 25, 2026 02:15 UTC
-
New flash glucose monitor aims to simplify diabetes management
Disease control Recruiting nowThis study tests a new device called the Eversense Gemini System, which helps people with diabetes check their blood sugar levels without finger sticks. About 80 adults with type 1 or type 2 diabetes will use the system to see how accurate and safe it is compared to standard moni…
Phase: NA • Sponsor: Senseonics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC